Shared Mechanisms of Neurodegeneration in Alzheimer’s Disease and Parkinson’s Disease
Open Access
- 12 May 2014
- journal article
- review article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2014, 1-8
- https://doi.org/10.1155/2014/648740
Abstract
Alzheimer’s disease (AD) and Parkinson’s disease (PD) have markedly different clinical and pathological features, but these two diseases are the most common neurodegenerative disorders. Previous studies have showed that there are common mechanisms in AD and PD. Several genetic studies have revealed mutations in genes associated with the risk of AD and PD. Circumstantial evidences have shown that dysregulation of brain iron homeostasis leads to abnormal iron accumulation and results in AD as well as PD.α-Synuclein and tau take part in the mechanisms of these diseases by oxidative stress and mitochondrial dysfunction. Some studies indicated that the loss of LC noradrenergic neurons may occur early in the progression of AD and PD. Nicotinic acetylcholine receptors (nAChRs) are members of the Cys-loop superfamily of pentameric ligand-gated ion channels; some evidence showed that nicotinic receptors may be associated with AD and PD. These experimental and clinical studies may provide a scientific foundation for common shared mechanisms in AD and PD.Keywords
This publication has 67 references indexed in Scilit:
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson diseaseFree Radical Biology & Medicine, 2013
- Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s DiseasePLOS ONE, 2013
- Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic MicePLOS ONE, 2012
- Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implicationsMolecular Neurodegeneration, 2012
- Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseasesNeurobiology of Aging, 2012
- Dysregulation of Iron Metabolism in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral SclerosisAdvances in Pharmacological Sciences, 2011
- Neuroprotective strategies involving ROS in Alzheimer diseaseFree Radical Biology & Medicine, 2011
- Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's diseaseBrain Research, 2011
- L-DOPA Neurotoxicity Is Mediated by Up-Regulation of DMT1−IRE ExpressionPLOS ONE, 2009
- Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 2008